Skip to search
Skip to main content
Title starts with
Author (sorted by title)
Call number (browse)
Princeton University Library Catalog
Antisense RNA Design, Delivery, and Analysis [electronic resource] / edited by Virginia Arechavala-Gomeza, Alejandro Garanto.
1st ed. 2022.
New York Springer Nature 2022
New York, NY : Springer US : Imprint: Humana, 2022.
1 online resource (XVII, 422 p. 69 illus., 59 illus. in color.)
Methods in Molecular Biology, 2434
[More in this series]
Methods in Molecular Biology, 1940-6029 ; 2434
[More in this series]
This open access volume gathers a variety of models, delivery systems, and approaches that can be used to assess RNA technology for exploiting antisense as a therapeutic intervention. Beginning with a section on the design of antisense technology and their delivery, the book continues by covering model systems developed to evaluate efficacy, both in vivo and in vitro, as well as methods to evaluate preclinically the toxicity associated with these new potential drugs, and intellectual property considerations. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and practical, Antisense RNA Design, Delivery, and Analysis provides basic knowledge and a large collection of methods to facilitate the work of newcomers to this vibrant and expanding field. This book was conceived thanks to the network DARTER (Delivery of Antisense RNA Therapeutics). DARTER is funded by the EU Cooperation of Science and Technology (COST), which aims to enhance interaction and collaborations between researchers in Europe and other countries.
European Cooperation in Science and Technology
Introduction and History of the Chemistry of Nucleic Acids Therapeutics
Antisense RNA Therapeutics: A Brief Overview
Design of Bifunctional Antisense Oligonucleotides for Exon Inclusion
Design and Delivery of SINEUP: A New Modular Tool to Increase Protein Translation
How to Design U1 snRNA Molecules for Splicing Rescue
Conjugation of Nucleic Acids and Drugs to Gold Nanoparticles
Determination of Optimum Ratio of Cationic Polymers and Small Interfering RNA with Agarose Gel Retardation Assay
Generation of Protein-Phosphorodiamidate Morpholino Oligomer Conjugates for Efficient Cellular Delivery via Anthrax Protective Antigen
Development and Use of Cellular Systems to Assess and Correct Splicing Defects
Modeling Splicing Variants Amenable to Antisense Therapy by Use of CRISPR-Cas9-Based Gene Editing in HepG2 Cells
In Vitro Models for the Evaluation of Antisense Oligonucleotides in Skin
In Vitro Delivery of PMOs in Myoblasts by Electroporation
Rapid Determination of MBNL1 Protein Levels by Quantitative Dot Blot for Evaluation of Antisense Oligonucleotides in Myotonic Dystrophy Myoblasts
Evaluation of Exon Skipping and Dystrophin Restoration in In Vitro Models of Duchenne Muscular Dystrophy
Generation of Human iPSC-Derived Myotubes to Investigate RNA-Based Therapies In Vitro
Eye on a Dish Models to Evaluate Splicing Modulation
Establishment of In Vitro Brain Models for AON Delivery
Considerations for Generating Humanized Mouse Models to Test Efficacy of Antisense Oligonucleotides
Generation of Humanized Zebrafish Models for the In Vivo Assessment of Antisense Oligonucleotide-Based Splice Modulation Therapies
Use of Small Animal Models for Duchenne and Parameters to Assess Efficiency upon Antisense Treatment
In Vivo Models for the Evaluation of Antisense Oligonucleotides in Skin
Delivery of Antisense Oligonucleotides to the Mouse Retina
Delivery of Antisense Oligonucleotides to the Mouse Brain by Intracerebroventricular Injections
Intrathecal Delivery of Therapeutic Oligonucleotides for Potent Modulation of Gene Expression in the Central Nervous System
Preclinical Safety Assessment of Therapeutic Oligonucleotides
Preclinical Evaluation of the Renal Toxicity of Oligonucleotide Therapeutics in Mice
Protocol for Isolation and Culture of Mouse Hepatocytes (HCs), Kupffer Cells (KCs), and Liver Sinusoidal Endothelial Cells (LSECs) in Analyses of Hepatic Drug Distribution
Patent Considerations When Embarking on New Antisense Drug Programs.
Show 25 more Contents items
Statement on language in description
Princeton University Library aims to describe library materials in a manner that is respectful to the individuals and communities who create, use, and are represented in the collections we manage.
Ask a Question
Suggest a Correction
Report Harmful Language
Antisense RNA design, delivery, and analysis / edited by Virginia Arechavala-Gomeza, Alejandro Garanto.